These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

951 related articles for article (PubMed ID: 32012470)

  • 41. MicroRNA-145 performs as a tumor suppressor in human esophageal squamous cell carcinoma by targeting phospholipase C epsilon 1.
    Tang C; He JY; Yu C; Wang PJ; Huang SH; Zheng HJ; Yan DQ; Zhang JH; Li Y
    J Cell Biochem; 2019 Jun; 120(6):10678-10687. PubMed ID: 30652343
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MiR-495 Inhibits Cisplatin Resistance and Angiogenesis in Esophageal Cancer by Targeting ATP7A.
    Li Z; Li S; Wen Y; Chen J; Liu K; Jia J
    Technol Cancer Res Treat; 2021; 20():15330338211039127. PubMed ID: 34747666
    [No Abstract]   [Full Text] [Related]  

  • 43. SEMA4D under the posttranscriptional regulation of HuR and miR-4319 boosts cancer progression in esophageal squamous cell carcinoma.
    Wang Y; Zhao H; Zhi W
    Cancer Biol Ther; 2020; 21(2):122-129. PubMed ID: 31651222
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MiR-143-3p functions as a tumor suppressor by regulating cell proliferation, invasion and epithelial-mesenchymal transition by targeting QKI-5 in esophageal squamous cell carcinoma.
    He Z; Yi J; Liu X; Chen J; Han S; Jin L; Chen L; Song H
    Mol Cancer; 2016 Jun; 15(1):51. PubMed ID: 27358073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum exosomal microRNA-766-3p expression is associated with poor prognosis of esophageal squamous cell carcinoma.
    Liu S; Lin Z; Zheng Z; Rao W; Lin Y; Chen H; Xie Q; Chen Y; Hu Z
    Cancer Sci; 2020 Oct; 111(10):3881-3892. PubMed ID: 32589328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The suppressive effects of microRNA-139-5p on proliferation and invasion of esophageal squamous cell carcinoma].
    Zheng LJ; Qu YH; Li SL; Yuan Q; Qi Y
    Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(13):956-965. PubMed ID: 33789378
    [No Abstract]   [Full Text] [Related]  

  • 47. LncRNA NRON negatively regulates cisplatin-induced cell apoptosis via downregulating miR-31 in esophageal squamous cell carcinomas.
    Liu B; Li X; Xie J; Feng Z; Lin N; Yu M
    In Vitro Cell Dev Biol Anim; 2022 Jan; 58(1):37-43. PubMed ID: 35075603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA-301b and its target gene synaptosome-associated protein 91 as important modulators in esophageal cancer: functional experiments.
    Pan F; Chen M; Song XY; Yang JD
    Anticancer Drugs; 2020 Apr; 31(4):411-422. PubMed ID: 31929350
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA signatures in chemotherapy resistant esophageal cancer cell lines.
    Hummel R; Sie C; Watson DI; Wang T; Ansar A; Michael MZ; Van der Hoek M; Haier J; Hussey DJ
    World J Gastroenterol; 2014 Oct; 20(40):14904-12. PubMed ID: 25356050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-30d inhibits the migration and invasion of human esophageal squamous cell carcinoma cells via the post‑transcriptional regulation of enhancer of zeste homolog 2.
    Xie R; Wu SN; Gao CC; Yang XZ; Wang HG; Zhang JL; Yan W; Ma TH
    Oncol Rep; 2017 Mar; 37(3):1682-1690. PubMed ID: 28184915
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F.
    Yang H; Wei YN; Zhou J; Hao TT; Liu XL
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3200-3206. PubMed ID: 28770965
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MiR-27b-3p exerts tumor suppressor effects in esophageal squamous cell carcinoma by targeting Nrf2.
    Han M; Li N; Li F; Wang H; Ma L
    Hum Cell; 2020 Jul; 33(3):641-651. PubMed ID: 32419118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis.
    Yang H; Su H; Hu N; Wang C; Wang L; Giffen C; Goldstein AM; Lee MP; Taylor PR
    BMC Cancer; 2020 May; 20(1):388. PubMed ID: 32375686
    [TBL] [Abstract][Full Text] [Related]  

  • 54. miR-4306 Suppresses Proliferation of Esophageal Squamous Cell Carcinoma Cell by Targeting SIX3.
    Yang C; Guo Z; Zhao Z; Wei Y; Wang X; Song Y
    Cell Biochem Biophys; 2021 Dec; 79(4):769-779. PubMed ID: 34021861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MiR-433-3p Inhibits Proliferation and Invasion of Esophageal Squamous Cell Carcinoma by Targeting GRB2.
    Shi Q; Wang Y; Mu Y; Wang X; Fan Q
    Cell Physiol Biochem; 2018; 46(5):2187-2196. PubMed ID: 29730656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Triptolide inhibits esophageal squamous cell carcinoma progression by regulating the circNOX4/miR-153-3p/SATB1 signaling pathway.
    Liang H; Che W; Peng F; Chen H; Xie X; Wu B
    Thorac Cancer; 2024 Mar; 15(7):538-549. PubMed ID: 38268309
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA‑216a‑5p suppresses esophageal squamous cell carcinoma progression by targeting KIAA0101.
    Sun T; An Q; Yan R; Li K; Zhu K; Dang C; Yuan D
    Oncol Rep; 2020 Nov; 44(5):1971-1984. PubMed ID: 32901882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circular RNA circ-Foxo3 inhibits esophageal squamous cell cancer progression via the miR-23a/PTEN axis.
    Xing Y; Zha WJ; Li XM; Li H; Gao F; Ye T; Du WQ; Liu YC
    J Cell Biochem; 2020 Mar; 121(3):2595-2605. PubMed ID: 31680314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemo-resistance in esophageal cancer cells via regulation of PTEN.
    Jin YY; Chen QJ; Xu K; Ren HT; Bao X; Ma YN; Wei Y; Ma HB
    Mol Cell Biochem; 2016 Nov; 422(1-2):161-170. PubMed ID: 27644195
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CircDUSP16 Contributes to Cell Development in Esophageal Squamous Cell Carcinoma by Regulating miR-497-5p/TKTL1 Axis.
    Ma L; Li H; Lin Y; Wang G; Xu Q; Chen Y; Xiao K; Rao X
    J Surg Res; 2021 Apr; 260():64-75. PubMed ID: 33326930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.